Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://onco.news/index.php/journal/article/view/73 |
Resumo: | The subcutaneous formulations of Trastuzumab (Herceptin®) and Rituximab (MabThera®) are more comfortable for the people affected by cancer who need this type of treatment and are also easier to prescribe, prepare and administer. This type of formulations demands nurses to update their knowledge, so that good practices are assured in the health care setting. With the purpose to support nurses in this matter, the Portuguese Oncology Nursing Association developed two documents with recommendations for administration of subcutaneous Rituximab and Trastuzumab. A group of expert cancer nurses evaluated the applicability of those documents and concluded that they facilitate to standardize procedures and to guide nursing interventions, which might help in the education and follow-up of the people affected by cancer who are under this type of anti-cancer treatments. |
id |
RCAP_7ddee8c7bd83aad4b225c2b12602cc8b |
---|---|
oai_identifier_str |
oai:oai.onco.news:article/73 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)RituximabTrastuzumabSubcutâneoIntervenções de enfermagemBoas práticasEnfermagem oncológicaRituximabTrastuzumabSubcutaneousNursing interventionsGood practicesCancer nursingThe subcutaneous formulations of Trastuzumab (Herceptin®) and Rituximab (MabThera®) are more comfortable for the people affected by cancer who need this type of treatment and are also easier to prescribe, prepare and administer. This type of formulations demands nurses to update their knowledge, so that good practices are assured in the health care setting. With the purpose to support nurses in this matter, the Portuguese Oncology Nursing Association developed two documents with recommendations for administration of subcutaneous Rituximab and Trastuzumab. A group of expert cancer nurses evaluated the applicability of those documents and concluded that they facilitate to standardize procedures and to guide nursing interventions, which might help in the education and follow-up of the people affected by cancer who are under this type of anti-cancer treatments.As formulações subcutâneas de Trastuzumab (Herceptin®) e Rituximab (MabThera®) têm a vantagem de permitir uma maior comodidade para a pessoa com doença oncológica e maior facilidade na prescrição, preparação e administração. A introdução deste tipo de formulações nos modos de administração de terapêutica antineoplásica exige, por parte dos enfermeiros, uma atualização de conhecimentos, que permita assegurar boas práticas na prestação de cuidados. Com o objetivo de suportar este processo, a Associação de Enfermagem Oncológica Portuguesa desenvolveu dois documentos (“Linhas de Consenso”), com recomendações para os enfermeiros que administram as terapêuticas antineoplásicas Rituximab e Trastuzumab, nas formulações subcutâneas. Um grupo de enfermeiros peritos avaliou a aplicabilidade destes documentos e concluiu que a utilização das “Linhas de Consenso” permite uniformizar procedimentos e orientar as intervenções de enfermagem, o que pode facilitar uma melhoria na educação e acompanhamento da pessoa com doença oncológica.AEOP – Associação de Enfermagem Oncológica Portuguesa2018-06-20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/73Onco.news; No. 36 (2018): Onco.News Journal (january-june); 20-25Onco.News; N.º 36 (2018): Revista Onco.News (janeiro-junho); 20-252183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/73https://onco.news/index.php/journal/article/view/73/90Direitos de Autor (c) 2018 Alice Monteiro , Carlos Góis , Cristina Lacerda, Elisabete Valério, Helena Xavier , Ortélia Dias , Sandra Ponte, Sara Torcato Parreirainfo:eu-repo/semantics/openAccessMonteiro , AliceGóis , CarlosLacerda, CristinaValério, ElisabeteXavier , HelenaDias , OrtéliaPonte, SandraTorcato Parreira, Sara2024-03-16T07:55:16Zoai:oai.onco.news:article/73Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:20.902135Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®) |
title |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) |
spellingShingle |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) Monteiro , Alice Rituximab Trastuzumab Subcutâneo Intervenções de enfermagem Boas práticas Enfermagem oncológica Rituximab Trastuzumab Subcutaneous Nursing interventions Good practices Cancer nursing |
title_short |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) |
title_full |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) |
title_fullStr |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) |
title_full_unstemmed |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) |
title_sort |
Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®) |
author |
Monteiro , Alice |
author_facet |
Monteiro , Alice Góis , Carlos Lacerda, Cristina Valério, Elisabete Xavier , Helena Dias , Ortélia Ponte, Sandra Torcato Parreira, Sara |
author_role |
author |
author2 |
Góis , Carlos Lacerda, Cristina Valério, Elisabete Xavier , Helena Dias , Ortélia Ponte, Sandra Torcato Parreira, Sara |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Monteiro , Alice Góis , Carlos Lacerda, Cristina Valério, Elisabete Xavier , Helena Dias , Ortélia Ponte, Sandra Torcato Parreira, Sara |
dc.subject.por.fl_str_mv |
Rituximab Trastuzumab Subcutâneo Intervenções de enfermagem Boas práticas Enfermagem oncológica Rituximab Trastuzumab Subcutaneous Nursing interventions Good practices Cancer nursing |
topic |
Rituximab Trastuzumab Subcutâneo Intervenções de enfermagem Boas práticas Enfermagem oncológica Rituximab Trastuzumab Subcutaneous Nursing interventions Good practices Cancer nursing |
description |
The subcutaneous formulations of Trastuzumab (Herceptin®) and Rituximab (MabThera®) are more comfortable for the people affected by cancer who need this type of treatment and are also easier to prescribe, prepare and administer. This type of formulations demands nurses to update their knowledge, so that good practices are assured in the health care setting. With the purpose to support nurses in this matter, the Portuguese Oncology Nursing Association developed two documents with recommendations for administration of subcutaneous Rituximab and Trastuzumab. A group of expert cancer nurses evaluated the applicability of those documents and concluded that they facilitate to standardize procedures and to guide nursing interventions, which might help in the education and follow-up of the people affected by cancer who are under this type of anti-cancer treatments. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-06-20 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://onco.news/index.php/journal/article/view/73 |
url |
https://onco.news/index.php/journal/article/view/73 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://onco.news/index.php/journal/article/view/73 https://onco.news/index.php/journal/article/view/73/90 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
dc.source.none.fl_str_mv |
Onco.news; No. 36 (2018): Onco.News Journal (january-june); 20-25 Onco.News; N.º 36 (2018): Revista Onco.News (janeiro-junho); 20-25 2183-6914 1646-7868 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138187218518016 |